← Eichor
Condition: Neuroblastoma Recurrent Refractory Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Neuroblastoma Recurrent Refractory

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial
Phase 2 · 13 location(s) · New Approaches to Neuroblastoma Therapy Consortium · NCT06450041Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma
Phase 1 · 2 location(s) · Nanjing Children's Hospital · NCT06751134A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Pat
Phase 2 · 4 location(s) · St. Jude Children's Research Hospital · NCT07085338Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma
Phase 1/Phase 2 · 2 location(s) · Roberto Chiarle · NCT06803875NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Phase 1/Phase 2 · 1 location(s) · Nationwide Children's Hospital · NCT04211675NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neurob
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT07211737PEEL-224, Vincristine and Temozolomide in Pediatric Solid Tumors
Phase 1/Phase 2 · 7 location(s) · Theodore Laetsch · NCT06721689Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Phase 1/Phase 2 · 10 location(s) · St. Jude Children's Research Hospital · NCT04901702GPC2 CAR T Cells for Relapsed or Refractory Neuroblastoma and Metastatic Retinoblastoma
Phase 1 · 1 location(s) · Stephan Grupp MD PhD · NCT05650749GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults
Phase 1 · 1 location(s) · Stanford University · NCT07087002A Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
EARLY_Phase 1 · 1 location(s) · The General Hospital of Western Theater Command · NCT06684639Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or R
Phase 1 · 2 location(s) · Steven DuBois, MD · NCT07027748Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma
Phase 1 · 1 location(s) · Marzieh Ebrahimi · NCT06674265Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Ris
Phase 3 · 1 location(s) · Federal Research Institute of Pediatric Hematology, Oncology · NCT07375563APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors
Phase 1 · 3 location(s) · Ascentage Pharma Group Inc. · NCT05701306Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treat
Phase 1/Phase 2 · 1 location(s) · Fundación de investigación HM · NCT06607692177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma
Phase 2 · 5 location(s) · Jakob Stenman · NCT04903899Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic
Phase 1 · 1 location(s) · Sun Yat-sen University · NCT07584499Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma
Phase 1/Phase 2 · 1 location(s) · Beijing Biotech · NCT07502287Phase II Study of Chidamide-Dinutuximab Beta-Irinotecan-Temozolomide for Refractory/Relapsed Neuroblastoma in Children
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07318831Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Singl
Phase 1/Phase 2 · 1 location(s) · Sun Yat-sen University · NCT05027386Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Phase 1/Phase 2 · 21 location(s) · Children's Oncology Group · NCT04851119Quadruple Immunotherapy for Neuroblastoma
Phase 2 · 1 location(s) · Hong Kong Children's Hospital · NCT05754684Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/
Phase 1 · 1 location(s) · Emory University · NCT05400603Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Ma
Phase 2 · 1 location(s) · Memorial Sloan Kettering Cancer Center · NCT00107289Clinical Analysis of Naxitamab (hu3F8) in the Treatment of Pediatric High Risk or Refractory/ Relapsed Neuroblastoma
Phase 2 · 1 location(s) · Sun Yat-Sen University Cancer Center · NCT06013618
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.